Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target Austria16864859.0Filed on 2018-05-18
TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES Read more about TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES Patent Cooperation TreatyPCT/US2025/017061Filed on 2025-02-24
Synergistic Interactions For Improved Cancer Treatment Read more about Synergistic Interactions For Improved Cancer Treatment European Patent23768747.0Filed on 2025-01-29
Synergistic Interactions For Improved Cancer Treatment Read more about Synergistic Interactions For Improved Cancer Treatment US Application 19/101,938Filed on 2025-02-07
SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES Read more about SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES US Application 19/107,498Filed on 2025-02-27
PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES India202417104351Filed on 2024-12-30
T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 Japan2025-020882Filed on 2025-02-12
TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 Read more about TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 Hong Kong42025102573.0Filed on 2025-01-22
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY United Kingdom19707555.9Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Germany19707555.9Filed on 2019-02-08